Asia Pacific Acetaminophen Reagents Market

Market Introduction

The APAC is the fastest-growing regional market for acetaminophen reagents; and China, India, Japan, South Korea, Australia, and Rest of APAC are the major contributors to the market in this region. APAC is likely to account for over 19.42% market share of the market in 2021 owing to the growing investments from international players in China and India. With strong business prospects in the APAC, companies are focusing on widening product portfolio, diversified business operations, lower costs, user satisfaction, and improve Acetaminophen API reliability. Acetaminophen is also known as paracetamol. China and India, two largest API producers in the world, supply 80% of the global paracetamol market, leading Asia to be the largest origin of paracetamol. Meanwhile, the huge population makes it the largest consumption market of the world. Asia has consumed approx. 64,900 tons of paracetamol in 2018, though part of that is exported in the form of formulation. As the economy develops, Asia market will be more important. In a multi-ethnic Asian community, the rate of paracetamol-induced hepatotoxicity was low, at 7.3 percent. Despite high doses of paracetamol and late presentations to the hospital, there was no mortality or morbidity. Limited players present in the market and rising technological advancements in immunoassay-based acetaminophen reagents are the major factor driving the growth of the APAC acetaminophen reagents market.

In case of COVID-19, APAC is highly affected specially India. COVID-19 pandemic has poised an unprecedented sanitary risk. Paracetamol or acetaminophen is suggested as an alternative to ibuprofen for treating COVID-19 symptoms. Drugs that may decrease the brutality of the infection and decrease the high mortality rate. To this end, several medicines have been repurposed, including paracetamol. It can help to relieve patients with these symptoms; however, it is not a cure against COVID-19. Pharmacies have been running short of Acetaminophen and some shops have been limiting the sales of these drugs. Although, pharmaceutical companies have improved their production capacity significantly to keep pace with the growing demand for the drugs. In turn, it is projected to have a positive impact on the target industry growth. However, the market has stabilized compared to the initial phases of the pandemic owing to the control procedures, awareness among people, availability of vaccinations, and supportive government policies of the business in the related market. There was a big impact of COVID-19 in APAC has been the closure of and disruption to health services for mothers and children across the region. Most children have asymptomatic or mild diseases that parents can handle at home. The treatment is symptomatic, with paracetamol for fever and careful monitoring for deterioration by assessing respiratory rates, difficulty breathing, oral intake, and oxygen saturation.

Market Overview and Dynamics

The APAC acetaminophen reagents market is expected to grow from US$ 104.80 million in 2021 to US$ 153.15 million by 2028; it is estimated to grow at a CAGR of 5.6% from 2021 to 2028. Acetaminophen is a commonly used oral antipyretic and analgesic with an excellent safety profile when administered in appropriate therapeutic doses. It is an over-the-counter (OTC) medicine and is widely available. Acetaminophen can be found in numerous products, due to which people underestimate its toxicity. Various OTC cold and flu medicines contain acetaminophen. The generalized dosage of acetaminophen in adults is up to 3,000 mg of single-ingredient acetaminophen a day and less than 3,000 mg for patients aged 65 years and above. Patients ingest excessive amounts of medicine as they misunderstand dosing directions or cannot recognize the availability of acetaminophen in more than one medication they are using. Consumption of more than decided amounts, especially 7,000 mg or more, can lead to severe overdose problems such as, acute hepatic failure, or become deadly. If a person consumes more than one of OTC medicines containing acetaminophen in the same period, a dangerously high amount of acetaminophen can be found in the blood that can damage the liver. If a patient has any liver or kidney disease history, then the usage of this drug first needs to be discussed with the healthcare provider. Acetaminophen overdose is one of the major causes of overdose-related acute hepatic failure and death. If the liver damage is severe, its transplant may be required to save the patient’s life. After developing liver failure, every third of patients require liver transplantation. As the incidence of acetaminophen overdose increases along with rising hospitalizations and emergency room visits, the need to reduce the strength of the acetaminophen medications and dose management in patients rises, this will demand for accurate testing to determine level of drug which will favor the growth of the APAC acetaminophen reagents market.

Key Market Segments

In terms of product, the antibody/substrate reagent segment accounted for the largest share of the APAC acetaminophen reagents market in 2020. In terms of application, the enzymatic assays segment held a larger market share of the APAC acetaminophen reagents market in 2020. Further, the hospitals segment held a larger share of the APAC acetaminophen reagents market based on end user in 2020.  

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the APAC acetaminophen reagents market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Abbott; American Screening Corporation, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Biorbyt Ltd.; EKF Diagnostics; Randox Laboratories, Ltd.; Sekisui Diagnostics; Siemens Healthineers AG; and Thermo Fisher Scientific Inc. among others.

Reasons to buy report

• To understand the APAC acetaminophen reagents market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC acetaminophen reagents market
• Efficiently plan M&A and partnership deals in APAC acetaminophen reagents market by identifying market segments with the most promising probable sales  
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC acetaminophen reagents market
• Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

APAC Acetaminophen Reagents Market Segmentation

APAC Acetaminophen Reagents Market - By Product

• Antibody/Substrate Reagent
• Enzyme Reagent
• Acetaminophen Antiserum
• Acetaminophen Fluorescein Tracer
• Pretreatment Solution

APAC Acetaminophen Reagents Market -

By Application

• Enzymatic Assays
• Immunoassay 

APAC Acetaminophen Reagents Market -

By End User

• Hospitals
• Diagnostics Laboratories
• POC Testing
• Forensic Laboratories
• Others

APAC Acetaminophen Reagents Market - By Country

• Japan
• China
• India 
• South Korea
• Australia
• Rest of APAC

APAC Acetaminophen Reagents Market - Company Profiles

• Abbott
• American Screening Corporation, Inc.
• Beckman Coulter, Inc.
• Bio-Rad Laboratories, Inc.
• Biorbyt Ltd.         
• EKF Diagnostics
• Randox Laboratories, Ltd.
• Sekisui Diagnostics  
• Siemens Healthineers AG     
• Thermo Fisher Scientific Inc.

Asia Pacific Acetaminophen Reagents Strategic Insights

Strategic insights for the Asia Pacific Acetaminophen Reagents provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Acetaminophen Reagents Report Scope

Asia Pacific Acetaminophen Reagents Regional Insights

The geographic scope of the Asia Pacific Acetaminophen Reagents refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.